Peregrine Pharmaceuticals shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $621k | 93k | 6.70 |
| 2023-12-31 | $122k | 19k | 6.51 |
| 2023-09-30 | $378k | 40k | 9.45 |
| 2023-06-30 | $182k | 13k | 13.96 |
| 2022-12-31 | $502k | 36k | 13.78 |
| 2022-09-30 | $237k | 12k | 19.12 |
| 2022-06-30 | $1.1M | 74k | 15.27 |
| 2021-06-30 | $502k | 20k | 25.65 |
| 2020-09-30 | $323k | 42k | 7.62 |
| 2020-06-30 | $188k | 29k | 6.57 |
| 2020-03-31 | $535k | 105k | 5.11 |
| 2019-12-31 | $321k | 42k | 7.67 |
| 2019-06-30 | $188k | 34k | 5.60 |
| 2019-03-31 | $310k | 73k | 4.25 |
| 2018-09-30 | $163k | 24k | 6.88 |